The pharmacokinetics and pharmacodynamics of valsartan in the post-myocardial infarction population

Author： Benge Cassandra D Muldowney James A S

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.8, Iss.11, 2012-11, pp. : 1469-1482

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetics and Pharmacodynamics of Tenecteplase in Fibrinolytic Therapy of Acute Myocardial Infarction

By Tanswell P.

Clinical Pharmacokinetics, Vol. 41, Iss. 15, 2002-01 ,pp. : 1229-1245

Adis International

Access to resources Recommend Favorite

Calcium Antagonists in the Post-Myocardial Infarction Setting

By Bertolet B.D.

Drugs & Aging, Vol. 15, Iss. 6, 1999-12 ,pp. : 461-470

Adis International

Access to resources Recommend Favorite

Underutilization of -Adrenoceptor Antagonists Post-Myocardial Infarction

By Gutierrez Michael E. Labovitz Arthur J.

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 1, 2005-01 ,pp. : 23-29

Adis International

Access to resources Recommend Favorite

Fibrosis as a Therapeutic Target Post-Myocardial Infarction

Current Pharmaceutical Design, Vol. 11, Iss. 4, 2005-02 ,pp. : 477-487

Bentham Science Publishers

Access to resources Recommend Favorite

Regenerative Approaches to Post-Myocardial Infarction Heart Failure

Current Pharmaceutical Design, Vol. 20, Iss. 12, 2014-04 ,pp. : 1930-1940

Bentham Science Publishers

Access to resources Recommend Favorite